Gene · 5957
Papers1,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cancer-Associated Retinopathy Presenting with Paraneoplastic Cerebellar Degeneration in Tonsillar Squamous Cell Carcinoma: A Case Report. | Reports (MDPI) | 2026 | 42784032 | PubTator, text mining | PubMed |
| Reporter-guided photoreceptor differentiation in 2D culture using PGP1-hIPSCs: A comparable alternative to 3D organoid systems? | Mol Vis | 2026 | 42774032 | PubTator, text mining | PubMed |
| Early diagnosis of a case of Heidenhain variant of Creutzfeld-Jakob disease by cerebrospinal fluid real-time quaking-induced conversion test. | Prion | 2026 | 41894154 | PubTator, text mining | PubMed |
| CRISPR and Beyond: Genome-Editing Strategies in Retinal Stem Cell Research. | Cells | 2026 | 41892280 | PubTator, text mining | PubMed |
| The Immunopathogenesis of uveitis. | Front Med (Lausanne) | 2026 | 41877771 | PubTator, text mining | PubMed |
| Unidirectional Palsy of Torsional Saccades in Ataxia Associated with Anti-GAD Antibody. | Cerebellum | 2026 | 41872633 | PubTator, text mining | PubMed |
| Correlation between anti-retinal antibodies and lupus retinopathy in systemic lupus erythematosus. | Sci Rep | 2026 | 41826673 | PubTator, text mining | PubMed |
| Integrated Transcriptomic Analysis Identifies Immune Remodeling and Prognostic Signatures in Uveal Melanoma. | Int J Genomics | 2026 | 41768976 | PubTator, text mining | PubMed |
| Neuronal autoantibodies in neurodegenerative dementia: From evidence to clinical framework. | J Prev Alzheimers Dis | 2026 | 41763102 | PubTator, text mining | PubMed |
| Bilateral extramidline involvement in intracranial germinoma: diagnostic lessons from a complex presentation. | Arq Neuropsiquiatr | 2026 | 41760094 | PubTator, text mining | PubMed |
| Anti-IgLON5 encephalitis is associated with anti-retinal immunological reactivity without retinal alteration. | J Transl Autoimmun | 2026 | 41755996 | PubTator, text mining | PubMed |
| Editorial: Cerebrospinal fluid biomarkers in psychiatric and neurological disorders. | Front Psychiatry | 2026 | 41743034 | PubTator, text mining | PubMed |
| Prolonged Anti-Zic4 Antibody-Positive Cerebellar Degeneration Following COVID-19 Infection. | Neuropsychopharmacol Rep | 2026 | 41700551 | PubTator, text mining | PubMed |
| Mimics and Diagnostic Pitfalls of Anti-Adenylate Kinase 5 Limbic Encephalitis. | CNS Neurosci Ther | 2026 | 41568974 | PubTator, text mining | PubMed |
| Trisulfated Heparin Disaccharide (TS-HDS) Antibody-Positive Small Fiber Neuropathy Involving Sweat Gland Nerve Fibers After the Second Moderna Vaccination: A Case Report. | Cureus | 2025 | 41458851 | PubTator, text mining | PubMed |
| Enhanced text clustering and sentiment analysis framework for online education: a BIF-DCN approach in computer education. | PeerJ Comput Sci | 2025 | 40989355 | PubTator, text mining | PubMed |
| Opsoclonus-myoclonus-ataxia Syndrome in an ART-naïve Patient With CSF/Plasma HIV-1 RNA Discordance. | Open Forum Infect Dis | 2025 | 40980571 | PubTator, text mining | PubMed |
| Exon Skipping Therapy Restores Ciliary Function in USH2A-Related Retinal Degeneration. | Invest Ophthalmol Vis Sci | 2025 | 40970667 | PubTator, text mining | PubMed |
| Longitudinal Extensive Transverse Myelitis After Respiratory Syncytial Virus Vaccination With Positive Anti-Recoverin Antibodies. | Case Rep Neurol Med | 2025 | 40917683 | PubTator, text mining | PubMed |
| Seronegative Paraneoplastic Opsoclonus-Myoclonus-Ataxia Syndrome Secondary to Low Volume Endocrine-Sensitive Malignancy of Likely Breast Origin. | Curr Oncol | 2025 | 40862809 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5957/papers